The Patent With 25X Profit Potential

Posted On Oct 18, 2019 By Ray Blanco

For decades, we’ve taken an aggressive approach to treating cancer with chemotherapy. But thanks to this tiny biotech company, that’s all beginning to change…
Because one company has found a way to get all the amazing cancer-killing benefits of
chemo and radiation without all the collateral damage for certain blood cancers. And it all starts with Patent No. 34643-63.

Subscribe to Ray Blanco’s FDA Trader Today!

Ray Blanco’s FDA Trader focuses on medical tech stocks with prices that move based on triggers generally unknown to the market.

Subscribe Today!